Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy

Area of Science:

• Nephrology
• Lipidology
• Pathology

Background:

• Lipoprotein glomerulopathy is a rare renal disease characterized by "lipoprotein thrombi" in glomerular capillaries.
• This condition has been identified in six patients through renal histology.

Purpose of the Study:

• To investigate the clinical and biochemical characteristics of lipoprotein glomerulopathy.
• To explore the association between apolipoprotein E levels, lipoprotein profiles, and the development of lipoprotein thrombi.

Main Methods:

• Analysis of clinical data and renal histology from six patients with lipoprotein glomerulopathy.
• Biochemical assays including lecithin-cholesterol acyltransferase (LCAT) activity, lipoprotein profiling, and plasma apolipoprotein E (apo E) levels.
• Comparison with control groups: hyperlipidemic nephrotic syndrome without thrombi and type IIb hyperlipoproteinemia without renal disease.

Main Results:

• All six patients exhibited proteinuria (1.6-10 g/d) and normal LCAT activity.
• Patients presented with type III hyperlipoproteinemia-like lipoprotein profiles.
• Significantly elevated plasma apo E levels (>10 mg/dL) were observed compared to controls (P < 0.01).
• Apo E isoforms were predominantly rare (five E2/3, one E4/4), distinguishing it from familial type III hyperlipoproteinemia.

Conclusions:

• Elevated apolipoprotein E levels, in conjunction with specific apo E isoforms and lipoprotein metabolic derangements, are strongly associated with lipoprotein glomerulopathy.
• The findings suggest a causal link between apo E-related hyperlipoproteinemia and the formation of lipoprotein thrombi in the renal glomeruli.
• Further research is warranted to elucidate the precise mechanisms connecting apo E metabolism and thrombus formation in this renal disease.